Agilon
-
Biologics
Biogennix Launches Agilon Surgical Matrix
Osteobiologics Leader Enters Wound Care Space with Cutting Edge Solution IRVINE, Calif., July 24, 2024 – OrthoSpineNews – Biogennix, an…
Read More » -
Biologics
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable and Morpheus Moldable Products
Agilon Moldable Morpheus Moldable IRVINE, Calif. — May 8, 2024 — Irvine-based Biogennix, LLC an osteobiologics company specializing in bone…
Read More » -
Biologics
Biogennix’s Agilon Moldable Bone Graft Solution Achieves Sales Surge Amid Adoption by Foot and Ankle Surgeons
IRVINE, Calif. — May 19, 2021 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
Biogennix Launches Agilon Strip Advanced Bone Grafting Solution
IRVINE, Calif. — April 14, 2021 — Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft…
Read More » -
Biologics
Biogennix Receives FDA Clearance for Expanded Use of Agilon Moldable Bone Grafting Solution in Spine Procedures
March 04, 2020 IRVINE, Calif.–(BUSINESS WIRE)–Irvine-based Biogennix, an osteobiologics company that develops, manufactures, and distributes proprietary bone graft products used for…
Read More »